Invivyd
IVVD
Invivyd (IVVD) news
Recent news
Invivyd reports inducement grants under Nasdaq listing rule 5635(c)(4)
AInvest Wire · Aug 4, 2026Invivyd sees topline data in 3Q
AInvest Wire · Jun 16, 2026Invivyd - to report Liberty study results in Q3 2026
AInvest Wire · Jun 16, 2026Invivyd reports inducement grants under Nasdaq listing rule 5635(c)(4)
AInvest Wire · Jun 3, 2026Invivyd Q4 revenue up 25% YoY to $17.2mln, cash at $226.7mln.
• Invivyd Q4 2025 PEMGARDA net revenue: $17.2 million, 25% YoY growth • 2025 year-end cash: $226.7 million • Declaring Phase 3 trial for COVID vaccine alternative VYD2311 initiated • Fast Track designation granted for VYD2311 • Declaring trial on track with full enrollment achieved • VYD2311 safety…
AInvest Wire · Mar 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.